Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
You have two non-negotiables
Supplied for in-vitro laboratory research only, not for human or veterinary use
Cardiovascular outcomes GLP-1 receptor agonists have demonstrated cardiovascular risk reduction in large outcome trials
Other sellers offer vials for thirty to ninety dollars and post certificates of analysis to signal quality, while their own copy concedes that rigorous human trials are lacking and that the benefits are, in their words, anecdotal and scientifically unproven
Suitable for Varied Populations: By design, AOD-9604 aims to be well-tolerated without drastically affecting blood sugar or other hormonal pathways
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
